fenton's reagent has been researched along with oxidopamine in 2 studies
| Studies (fenton's reagent) | Trials (fenton's reagent) | Recent Studies (post-2010) (fenton's reagent) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 1,891 | 1 | 843 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | fenton's reagent (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correa, JG; Stoppani, AO | 1 |
| Bomhoff, GL; Geiger, PC; Morris, JK; Stanford, JA | 1 |
2 other study(ies) available for fenton's reagent and oxidopamine
| Article | Year |
|---|---|
Catecholamines enhance dihydrolipoamide dehydrogenase inactivation by the copper Fenton system. Enzyme protection by copper chelators.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding Sites; Captopril; Catecholamines; Catechols; Cattle; Chelating Agents; Copper; Cysteine; Dihydrolipoamide Dehydrogenase; Dopamine; Epinephrine; Hydrogen Peroxide; Hydroxyl Radical; Iron; Kinetics; Mammals; Norepinephrine; Oxidation-Reduction; Oxidopamine; Penicillamine | 1996 |
Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Chromatography, High Pressure Liquid; Dietary Fats; Dopamine; Eating; Epididymis; Glucose Tolerance Test; Hydrogen Peroxide; Insulin; Insulin Resistance; Iron; Male; Mice; Muscle, Skeletal; Neostriatum; Nerve Degeneration; Neurons; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Inbred F344; Substantia Nigra; Sympatholytics | 2010 |